Announced Thu, 10 Sept, 2026 · 16:12 IST
Board comments on SEBI fine for director appointment non-compliance
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹658.75
prior close
₹658.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.2-0.2-0.4-0.6-0.7-0.8-0.4-0.1+0.4-0.5———
Up moveDown movePending
AI summary
Medplus Health Services was fined by BSE and NSE for non-compliance with SEBI LODR Regulation 17(1A) regarding the appointment of Mr. Ajit Rangnekar as Non-Executive Independent Director after he turned 75 years old. The Board said this was a bona fide interpretational difference, not a willful default. Shareholders had already approved the appointment through a special resolution at the AGM on August 17, 2026. Board directed management to strengthen compliance systems.
Likely market impact
Minor governance issue already addressed. Shareholders approved the appointment. Limited stock impact expected.